United States

Top 538 largest US Companies in the Biotechnology industry by Market Cap

This is the list of the largest public listed companies in the Biotechnology industry from the United States by market capitalization with links to their reference stock.

United States Biotechnology Industry Analysis
Top US Companies United States Analysis
World Top Companies World Companies Analysis

Top Biotechnology Companies from the United States as of Jul. 01, 2025

Download Excel

Rank Company Market Cap (USD) Country Sector Industry
301 Ikena Oncology, Inc. $64.2 M United States US Healthcare US Biotechnology
302 Clearside Biomedical, Inc. $63.1 M United States US Healthcare US Biotechnology
303 Gritstone bio, Inc. $63.0 M

(July 1, 2024)

United States US Healthcare US Biotechnology
304 PMV Pharmaceuticals, Inc. $61.8 M United States US Healthcare US Biotechnology
305 MediciNova, Inc. $61.3 M United States US Healthcare US Biotechnology
306 PDS Biotechnology Corporation $60.8 M United States US Healthcare US Biotechnology
307 Surface Oncology, Inc. $59.2 M

(July 1, 2023)

United States US Healthcare US Biotechnology
308 INmune Bio, Inc. $59.2 M United States US Healthcare US Biotechnology
309 VistaGen Therapeutics, Inc. $58.3 M United States US Healthcare US Biotechnology
310 Atara Biotherapeutics, Inc. $57.5 M United States US Healthcare US Biotechnology
311 Vicapsys Life Sciences, Inc. $57.3 M United States US Healthcare US Biotechnology
312 Artemis Therapeutics, Inc. $55.8 M

(May 1, 2023)

United States US Healthcare US Biotechnology
313 Fortress Biotech, Inc. $55.6 M United States US Healthcare US Biotechnology
314 Kronos Bio, Inc. $53.7 M United States US Healthcare US Biotechnology
315 Tyme Technologies, Inc. $53.5 M

(Sept. 1, 2022)

United States US Healthcare US Biotechnology
316 Sigilon Therapeutics, Inc. $53.3 M

(July 1, 2023)

United States US Healthcare US Biotechnology
317 ABVC BioPharma, Inc. $52.8 M United States US Healthcare US Biotechnology
318 Cue Biopharma, Inc. $52.4 M United States US Healthcare US Biotechnology
319 Reneo Pharmaceuticals, Inc. $50.7 M

(July 1, 2024)

United States US Healthcare US Biotechnology
320 Gain Therapeutics, Inc. $50.6 M United States US Healthcare US Biotechnology
321 Adicet Bio, Inc. $50.2 M United States US Healthcare US Biotechnology
322 AlloVir, Inc. $49.5 M United States US Healthcare US Biotechnology
323 Inovio Pharmaceuticals, Inc. $48.8 M United States US Healthcare US Biotechnology
324 Aeglea BioTherapeutics, Inc. $48.6 M

(Jan. 1, 2024)

United States US Healthcare US Biotechnology
325 Werewolf Therapeutics, Inc. $48.0 M United States US Healthcare US Biotechnology
326 Aligos Therapeutics, Inc. $47.9 M United States US Healthcare US Biotechnology
327 Adverum Biotechnologies, Inc. $47.6 M United States US Healthcare US Biotechnology
328 Annovis Bio, Inc. $46.0 M United States US Healthcare US Biotechnology
329 Zivo Bioscience, Inc. $45.7 M United States US Healthcare US Biotechnology
330 Aileron Therapeutics, Inc. $45.7 M

(March 1, 2025)

United States US Healthcare US Biotechnology

Top Biotechnology Companies from the United States as of Jul. 01, 2025

301. Ikena Oncology, Inc.

Company Profile: Ikena Oncology, Inc.
Market Cap (USD): $64.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

302. Clearside Biomedical, Inc.

Company Profile: Clearside Biomedical, Inc.
Market Cap (USD): $63.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

303. Gritstone bio, Inc.

Company Profile: Gritstone bio, Inc.
Market Cap (USD): $63.0 M (July 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

304. PMV Pharmaceuticals, Inc.

Company Profile: PMV Pharmaceuticals, Inc.
Market Cap (USD): $61.8 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

305. MediciNova, Inc.

Company Profile: MediciNova, Inc.
Market Cap (USD): $61.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

306. PDS Biotechnology Corporation

Company Profile: PDS Biotechnology Corporation
Market Cap (USD): $60.8 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

307. Surface Oncology, Inc.

Company Profile: Surface Oncology, Inc.
Market Cap (USD): $59.2 M (July 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

308. INmune Bio, Inc.

Company Profile: INmune Bio, Inc.
Market Cap (USD): $59.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

309. VistaGen Therapeutics, Inc.

Company Profile: VistaGen Therapeutics, Inc.
Market Cap (USD): $58.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

310. Atara Biotherapeutics, Inc.

Company Profile: Atara Biotherapeutics, Inc.
Market Cap (USD): $57.5 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

311. Vicapsys Life Sciences, Inc.

Company Profile: Vicapsys Life Sciences, Inc.
Market Cap (USD): $57.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

312. Artemis Therapeutics, Inc.

Company Profile: Artemis Therapeutics, Inc.
Market Cap (USD): $55.8 M (May 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

313. Fortress Biotech, Inc.

Company Profile: Fortress Biotech, Inc.
Market Cap (USD): $55.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

314. Kronos Bio, Inc.

Company Profile: Kronos Bio, Inc.
Market Cap (USD): $53.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

315. Tyme Technologies, Inc.

Company Profile: Tyme Technologies, Inc.
Market Cap (USD): $53.5 M (Sept. 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

316. Sigilon Therapeutics, Inc.

Company Profile: Sigilon Therapeutics, Inc.
Market Cap (USD): $53.3 M (July 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

317. ABVC BioPharma, Inc.

Company Profile: ABVC BioPharma, Inc.
Market Cap (USD): $52.8 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

318. Cue Biopharma, Inc.

Company Profile: Cue Biopharma, Inc.
Market Cap (USD): $52.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

319. Reneo Pharmaceuticals, Inc.

Company Profile: Reneo Pharmaceuticals, Inc.
Market Cap (USD): $50.7 M (July 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

320. Gain Therapeutics, Inc.

Company Profile: Gain Therapeutics, Inc.
Market Cap (USD): $50.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

321. Adicet Bio, Inc.

Company Profile: Adicet Bio, Inc.
Market Cap (USD): $50.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

322. AlloVir, Inc.

Company Profile: AlloVir, Inc.
Market Cap (USD): $49.5 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

323. Inovio Pharmaceuticals, Inc.

Company Profile: Inovio Pharmaceuticals, Inc.
Market Cap (USD): $48.8 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

324. Aeglea BioTherapeutics, Inc.

Company Profile: Aeglea BioTherapeutics, Inc.
Market Cap (USD): $48.6 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

325. Werewolf Therapeutics, Inc.

Company Profile: Werewolf Therapeutics, Inc.
Market Cap (USD): $48.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

326. Aligos Therapeutics, Inc.

Company Profile: Aligos Therapeutics, Inc.
Market Cap (USD): $47.9 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

327. Adverum Biotechnologies, Inc.

Company Profile: Adverum Biotechnologies, Inc.
Market Cap (USD): $47.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

328. Annovis Bio, Inc.

Company Profile: Annovis Bio, Inc.
Market Cap (USD): $46.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

329. Zivo Bioscience, Inc.

Company Profile: Zivo Bioscience, Inc.
Market Cap (USD): $45.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

330. Aileron Therapeutics, Inc.

Company Profile: Aileron Therapeutics, Inc.
Market Cap (USD): $45.7 M (March 1, 2025)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

Stay in touch